Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-08 4:16 pm Sale |
2023-12-31 | 13G | Pharvaris N.V. PHVS |
LSP V Cooperatieve U.A. | 3,556,805 6.800% |
-50,761 (-1.41%) |
Filing History |
| 2023-02-24 07:00 am Unchanged |
2023-02-23 | 13D | Immunic, Inc. IMUX |
LSP V Cooperatieve U.A. | 2,162,782 4.900% |
0 (Unchanged) |
Filing History |
| 2023-02-10 07:06 am Sale |
2022-12-31 | 13G | Orphazyme A/S ORPHY |
LSP V Cooperatieve U.A. | 2,426,711 6.900% |
-169,450 (-6.53%) |
Filing History |
| 2022-02-03 4:18 pm Purchase |
2021-12-31 | 13G | Pharvaris N.V. PHVS |
LSP V Cooperatieve U.A. | 3,607,566 10.900% |
3,607,566 (New Position) |
Filing History |
| 2022-02-03 4:16 pm Sale |
2021-12-31 | 13G | Orphazyme A/S ORPHY |
LSP V Cooperatieve U.A. | 2,596,161 7.000% |
-114,668 (-4.23%) |
Filing History |
| 2022-02-03 4:16 pm Unchanged |
3021-12-31 | 13D | Eloxx Pharmaceuticals, Inc. ELOX |
LSP V Cooperatieve U.A. | 73,842 3.400% |
0 (Unchanged) |
Filing History |
| 2021-02-08 4:15 pm Purchase |
2020-12-31 | 13G | Orphazyme A/S ORPHY |
LSP V Cooperatieve U.A. | 2,710,829 7.800% |
2,710,829 (New Position) |
Filing History |
| 2020-09-04 4:15 pm Unchanged |
2020-08-07 | 13D | Immunic, Inc. IMUX |
LSP V Cooperatieve U.A. | 2,162,782 10.400% |
0 (Unchanged) |
Filing History |